Log in

CVE:MBIMed Biogene Stock Price, Forecast & News

Add
Compare
Today's Range N/A
50-Day Range
C$0.05
MA: C$0.05
C$0.07
52-Week Range N/A
Volume2,000 shs
Average Volume29,135 shs
Market CapitalizationC$795,000.00
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Med BioGene Inc., a life science company, focuses on the development and commercialization of genomic-based clinical laboratory diagnostic tests for cancer. Its products include the GeneFx Lung, a gene expression-based test for early-stage non-small-cell lung cancer that assists in identifying patients for adjuvant chemotherapy. The company has a collaboration agreement with the University Health Network in Toronto. Med BioGene Inc. was founded in 2002 and is headquartered in Vancouver, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.50 out of 5 stars


Industry, Sector and Symbol

Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-604-7327332

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book ValueC$0.00 per share

Profitability

Miscellaneous

EmployeesN/A
Market CapC$795,000.00
Next Earnings Date5/25/2020 (Estimated)
OptionableOptionable

Receive MBI News and Ratings via Email

Sign-up to receive the latest news and ratings for MBI and its competitors with MarketBeat's FREE daily newsletter.


Med Biogene (CVE:MBI) Frequently Asked Questions

When is Med Biogene's next earnings date?

Med Biogene is scheduled to release its next quarterly earnings announcement on Monday, May 25th 2020. View our earnings forecast for Med Biogene.

Has Med Biogene been receiving favorable news coverage?

Media coverage about MBI stock has trended very negative recently, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Med Biogene earned a news impact score of -3.3 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View the latest news aboutMed Biogene.

Who are some of Med Biogene's key competitors?

Who are Med Biogene's key executives?

Med Biogene's management team includes the following people:
  • Dr. Iain Weir-Jones Ph.D., P.Eng., FGS, Chairman & CEO
  • Mr. Ibrahim Ghobrial, Chief Financial Officer

What is Med Biogene's stock symbol?

Med Biogene trades on the Canadian Venture Exchange (CVE) under the ticker symbol "MBI."

How do I buy shares of Med Biogene?

Shares of MBI and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

How big of a company is Med Biogene?

Med Biogene has a market capitalization of C$0.00.  View additional information about Med Biogene.

What is Med Biogene's official website?

The official website for Med Biogene is http://www.medbiogene.com/.

How can I contact Med Biogene?

Med Biogene's mailing address is 598 E Kent Ave South, VANCOUVER, BC V5X 4V6, Canada. The company can be reached via phone at +1-604-7327332.

This page was last updated on 4/5/2020 by MarketBeat.com Staff

Featured Article: Trading Ex-Dividend

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel